Literature DB >> 1609692

Evolution of white matter lesions in neurofibromatosis type 1: MR findings.

R J Sevick1, A J Barkovich, M S Edwards, T Koch, B Berg, T Lempert.   

Abstract

To characterize further the evolution of white matter lesions in neurofibromatosis type 1, we reviewed 68 MR images in 43 patients (age, 1-31 years), including 25 follow-up studies (mean interval, 27 months). Lesion number, location, morphology, signal characteristics, and contrast enhancement were assessed. Lesion characteristics and changes thereof were correlated with the patients' ages. Thirty-four patients (79%) had white matter lesions. These lesions were hyperintense on T2-weighted images, were isointense on T1-weighted images, and showed no mass effect or contrast enhancement in 31 patients; in three patients, T1-prolongation was observed (one with significant mass effect). None of the lesions evolved into a glioma. The most common locations were the cerebellum (49%), brainstem (22%), and internal capsule (19%). Nineteen patients had white matter lesions and follow-up studies. Lesions decreased in size or number in seven patients (average age, 13 years), showed no change in three (average age, 12 years), increased in size or number in four (average age, 5 years), and showed a mixed pattern (increased/decreased size/number) in four (average age, 7 years). White matter lesions in neurofibromatosis type 1 frequently increase in size or number early in childhood; this did not indicate neoplasia in our study. The lesions tend to resolve with increasing age. Lesion progression in a child more than 10 years old warrants close follow-up to rule out a neoplasm.

Entities:  

Mesh:

Year:  1992        PMID: 1609692     DOI: 10.2214/ajr.159.1.1609692

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  28 in total

1.  Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI.

Authors:  Christian Philipp Reinert; Martin Ulrich Schuhmann; Benjamin Bender; Isabel Gugel; Christian la Fougère; Jürgen Schäfer; Sergios Gatidis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-12-08       Impact factor: 9.236

2.  MR imaging of the corpus callosum in pediatric patients with neurofibromatosis type 1.

Authors:  E C Dubovsky; T N Booth; G Vezina; C A Samango-Sprouse; K M Palmer; C O Brasseux
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

3.  Age-related findings on MRI in neurofibromatosis type 1.

Authors:  Deepak S Gill; Shelley L Hyman; Adam Steinberg; Kathryn N North
Journal:  Pediatr Radiol       Date:  2006-08-16

4.  Diffusion tensor MR imaging in neurofibromatosis type 1: expanding the knowledge of microstructural brain abnormalities.

Authors:  José R L Ferraz-Filho; Antônio J da Rocha; Marcos P Muniz; Antônio S Souza; Eny M Goloni-Bertollo; Erika C Pavarino-Bertelli
Journal:  Pediatr Radiol       Date:  2011-10-28

5.  Discriminating between neurofibromatosis-1 and typically developing children by means of multimodal MRI and multivariate analyses.

Authors:  Federico Nemmi; Fabien Cignetti; Christine Assaiante; Stephanie Maziero; Fredrique Audic; Patrice Péran; Yves Chaix
Journal:  Hum Brain Mapp       Date:  2019-05-11       Impact factor: 5.038

Review 6.  Pediatric brain MRI in neurofibromatosis type I.

Authors:  Hans-J Mentzel; Jörg Seidel; Clemens Fitzek; Annegret Eichhorn; Susanna Vogt; Jürgen R Reichenbach; Felix Zintl; Werner A Kaiser
Journal:  Eur Radiol       Date:  2004-07-29       Impact factor: 5.315

Review 7.  Special issues in the management of gliomas in children with neurofibromatosis 1.

Authors:  I F Pollack; J J Mulvihill
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

8.  Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor.

Authors:  T A Rizvi; S Akunuru; G de Courten-Myers; R C Switzer; M L Nordlund; N Ratner
Journal:  Brain Res       Date:  1999-01-16       Impact factor: 3.252

Review 9.  Optic pathway gliomas: a review.

Authors:  Iris Fried; Uri Tabori; Tarik Tihan; Arun Reginald; Eric Bouffet
Journal:  CNS Oncol       Date:  2013-03

10.  Evaluation of the basal ganglia in neurofibromatosis type 1.

Authors:  Francesco Nicita; Claudio Di Biasi; Saadi Sollaku; Stefano Cecchini; Vincenzo Salpietro; Angelo Pittalis; Laura Papetti; Fabiana Ursitti; Fiorenza Ulgiati; Anna Maria Zicari; Gian Franco Gualdi; Enrico Properzi; Marzia Duse; Martino Ruggieri; Alberto Spalice
Journal:  Childs Nerv Syst       Date:  2013-07-27       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.